drugset
drugset / Trial / NCT04951869

: Protescal: Prevention of Hypertrophic Scar and Keloid Formation Post Caesarean Section

NCT04951869 ↗

Phase 2/3 Completed 90 enrolled Universiti Kebangsaan Malaysia Medical Centre
RandomizedParallel-groupSingle-blindPrevention

Summary

This study aimed to evaluate the effectiveness of Protescal in preventing post caesarean section hypertrophic scar and keloid formation.

Timeline

Start
2017-04-26
Primary completion
2017-10-31
Completion
2017-11-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Protescal gel Unknown 0.5 ml Topical

Indications

keloid